S

Saturn V Capital Management LLC Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for Saturn V Capital Management LLC with $456.0M in long positions as of Q3 2025, 81% allocated to Healthcare, and 77% concentrated in top 10 positions.

Portfolio Value
$456.0M
Top 10 Concentration
77%
Top Sector
Healthcare (81%)
US Exposure
77%
Market Cap Focus
Mid Cap
Countries
4

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 81.20%Healthcare
Healthcare
81.20%

Industry Breakdown

1 industry across all sectors

Biotechnology: 81.18%Biotechnology
Biotechnology
Healthcare
81.18%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mid Cap ($2B - $10B): 48.64%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 32.54%Small Cap ($300M - $2B)N/A (ETF or Unknown): 18.82%N/A (ETF or Unknown)
Mid Cap ($2B - $10B)
48.64%
Small Cap ($300M - $2B)
32.54%
N/A (ETF or Unknown)
18.82%

Portfolio Concentration

Top 10 Holdings %
77.4%
Top 20 Holdings %
100.0%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
77.27%
International
22.73%
Countries
4
Largest Int'l Market
Netherlands - 9.61%
United States of America
77.27% ($352.3M)
12 holdings
Netherlands
9.61% ($43.8M)
3 holdings
Ireland
8.69% ($39.6M)
1 holdings
Canada
4.44% ($20.2M)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
4.2 quarters
Avg. Top 20
3.6 quarters
Avg. All Positions
3.6 quarters
Median Holding Period
3 quarters
Persistence Rate
41.18%
Persistent Holdings Weight
46.52%
Persistent Positions
7
Longest Held
Cogent Biosciences, Inc. Common Stock logo
Cogent Biosciences, Inc. Common StockCOGT - 9 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
3.82%
Avg. Position Weight
5.88%
Largest Position
ABVX
Abivax SA American Depositary SharesABVX - 14.92%
Largest Ownership Stake
Amylyx Pharmaceuticals, Inc. Common Stock logo
Amylyx Pharmaceuticals, Inc. Common StockAMLX - 4.32%
Avg. Ownership Stake
1.29%
Ownership Stake >5%
0
Ownership Stake >1%
7

Historical (Since Q4 2022)

Avg. New Position
3.55%
Avg. Ownership Stake
0.98%
Largest Position
ASND
Ascendis Pharma A/S American Depositary SharesASND - 15.67% (Q1 2025)
Largest Ownership Stake
KalVista Pharmaceuticals, Inc. Common Stock logo
KalVista Pharmaceuticals, Inc. Common StockKALV - 5.26% (Q3 2023)

Portfolio Turnover

Current Quarter

Turnover Ratio
22.4%
Value Traded
$101.93M
Positions Added
2
Positions Exited
9

Historical (Since Q4 2022)

Avg. Turnover Ratio
26.2%
Avg. Positions Added
5
Avg. Positions Exited
4
Highest Turnover
50.0%
Q4 2022
Lowest Turnover
16.1%
Q4 2024

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.